Kitamura S, Sugihara K, Nakatani K, Ohta S, Ohhara T, Ninomiya S, Green C E, Tyson C A
Institute of Pharmaceutical Science, Hiroshima University School of Medicine, Japan.
IUBMB Life. 1999 Dec;48(6):607-11. doi: 10.1080/713803569.
This study deals with individual and species variations in the converting activity of methotrexate (MTX) to 7-hydroxymethotrexate in animals and humans. When MTX 7-hydroxylase was assayed in six human liver cytosols, a 48-fold range of intersubject variation of the activity was observed. The variations were correlated to the concentrations of aldehyde oxidase activity in human subjects assayed with benzaldehyde as a substrate. Species differences of liver MTX 7-hydroxylase activity were also observed. The activity was highest in rabbits, followed by rats, hamsters, and monkeys but was undetectable in dogs. Strain differences of MTX 7-hydroxylase activity based on aldehyde oxidase activity were also observed in rats and mice. The results suggest that aldehyde oxidase functions as MTX 7-hydroxylase in livers of animals and humans, and the observed differences of MTX 7-hydroxylase activity are due to variations in the amount of aldehyde oxidase present.
本研究探讨了动物和人类体内甲氨蝶呤(MTX)转化为7 - 羟基甲氨蝶呤的转化活性的个体差异和物种差异。当在六种人肝细胞溶胶中检测MTX 7 - 羟化酶时,观察到个体间活性变化范围达48倍。这些变化与以苯甲醛为底物检测的人类受试者中醛氧化酶活性的浓度相关。还观察到肝脏MTX 7 - 羟化酶活性的物种差异。该活性在兔子中最高,其次是大鼠、仓鼠和猴子,但在狗中未检测到。基于醛氧化酶活性的MTX 7 - 羟化酶活性的品系差异在大鼠和小鼠中也有观察到。结果表明,醛氧化酶在动物和人类肝脏中作为MTX 7 - 羟化酶发挥作用,并且观察到的MTX 7 - 羟化酶活性差异是由于醛氧化酶含量的变化所致。